Figure 3
Figure 3. FibrinogenAEK forms a polymer following incubation with enterokinase enzyme but not thrombin. Representative turbidity analyses using plasma isolated from WT (closed circles) and FibAEK (open symbols) mice following incubation with (A) thrombin or (B) enterokinase enzyme. Similar representative turbidity analyses using purified WT fibrinogen (closed circles) and fibrinogenAEK (open symbols) following incubation with (C) thrombin or (D) enterokinase enzyme. The purified fibrinogen concentration in each analysis was 0.04 mg/mL. To prevent spurious thrombin activity, reactions with enterokinase enzyme included the addition of the specific thrombin inhibitor lepirudin at 0.025 mg/mL. (E) Scanning electron micrographs of products formed from reaction mixtures of purified WT fibrinogen or fibrinogenAEK with thrombin or enterokinase. Scale bar, 2.5 μm.

FibrinogenAEK forms a polymer following incubation with enterokinase enzyme but not thrombin. Representative turbidity analyses using plasma isolated from WT (closed circles) and FibAEK (open symbols) mice following incubation with (A) thrombin or (B) enterokinase enzyme. Similar representative turbidity analyses using purified WT fibrinogen (closed circles) and fibrinogenAEK (open symbols) following incubation with (C) thrombin or (D) enterokinase enzyme. The purified fibrinogen concentration in each analysis was 0.04 mg/mL. To prevent spurious thrombin activity, reactions with enterokinase enzyme included the addition of the specific thrombin inhibitor lepirudin at 0.025 mg/mL. (E) Scanning electron micrographs of products formed from reaction mixtures of purified WT fibrinogen or fibrinogenAEK with thrombin or enterokinase. Scale bar, 2.5 μm.

Close Modal

or Create an Account

Close Modal
Close Modal